Medicine Range - D

Our range of generic and branded medicines and medical devices includes prescription medicines used in primary and secondary care and covers a broad range of therapeutic areas.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dapsone

Teva markets Dapsone. The Patient Information Leaflet for Dapsone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (0)

Dapsone

Teva markets Dapsone. The Patient Information Leaflet for Dapsone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117

View all medicines (1)
Available as
  • Tablets

Desflurane

Teva markets Desflurane. The Patient Information Leaflet for Desflurane from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117

View all medicines (1)
Available as
  • Inhalation Vapour

Device

Teva markets a number of devices. A medical device does not require the approval of a licence (SmPC) in the same way as a pharmaceutical drug does, therefore there will not be any documentation attached to this product on our website. If you require any further information please call or email our Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (8)
Available as
  • Device
  • Eye drops
  • Inhaler
  • Lotion
  • Ointment

Dexamethasone

Teva markets Dexamethasone. The Patient Information Leaflet for Dexamethasone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (7)
Available as
  • Oral solution
  • Spray
  • Tablets

Dexamfetamine

Teva markets Dexamfetamine. The Patient Information Leaflet for Dexamfetamine from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Tablets

Diazepam

Teva markets Diazepam. The Patient Information Leaflet for Diazepam from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (3)
Available as
  • Tablets

Diclofenac

Teva markets Diclofenac. The Patient Information Leaflet for Diclofenac from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (4)
Available as
  • GR Tablets

Dicycloverine

Teva markets Dicycloverine. The Patient Information Leaflet for Dicycloverine from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117

View all medicines (3)
Available as
  • Oral solution
  • Tablets

Diethylstilbestrol

Teva markets Diethylstilbestrol. The Patient Information Leaflet for Diethylstilbestrol from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Tablets

Digoxin

Teva markets Digoxin. The Patient Information Leaflet for Digoxin from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (3)
Available as
  • Tablets

Dihydrocodeine

Teva markets Dihydrocodeine. The Patient Information Leaflet for Dihydrocodeine from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Tablets

Diltiazem

Teva markets Diltiazem. The Patient Information Leaflet for Diltiazem from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (2)
Available as
  • CR Capsules

Dimethicone

Teva markets products containing Dimethicone. The Patient Information Leaflet for products containing Dimethicone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (4)
Available as
  • Cream

Disulfiram

Teva markets Disulfiram. The Patient Information Leaflet for Disulfiram from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Tablets

Docetaxel

Teva markets Docetaxel. The Patient Information Leaflet for Docetaxel from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117

View all medicines (1)
Available as
  • Concentrate for Infusion

Dorzolamide

Teva markets Dorzolamide. The Patient Information Leaflet for Dorzolamide from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Eye drops

Dosulepin

Teva markets Dosulepin. The Patient Information Leaflet for Dosulepin from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (3)
Available as
  • Capsules
  • Tablets

Doxazosin

Teva markets Doxazosin. The Patient Information Leaflet for Doxazosin from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (7)
Available as
  • PR Tablets
  • Tablets
1 2

Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get through the Yellow Card Scheme.

Date of preparation: August 2021
Reference: COB-GB-NP-00077

Date of preparation: August 2021
Reference: COB-GB-NP-00078